AI Likeness Rights in Brand Deals Why Creator Contracts Lag Behind the Technology Roundhill Memory ETF Surges Past 10 Billion in Assets Driven by AI Memory Demand US Payrolls Beat Expectations in April but Underlying Weaknesses Raise Concerns Global GBTG Q1 2026 Earnings EPS 010 Beats Estimates VanEck ETF Inflows Approach 1 Billion in Latest Weekly Data Uber and DoorDash Explore Investor Backing for Potential Delivery Hero Acquisition FT Reports Preparing for Winter Energy Costs Expert Tips to Lower Your Bills SP 500 Flat as Consumer Stocks Rally Offsets Energy Drag AMD Announces Over 10 Billion Investment in Taiwans AI and Chip Ecosystem to Boost NextGen Processors Fed Faces Historic Overlap as Powell and Warsh Prepare for Unprecedented Collaboration AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline AMTX Q1 2026 Earnings Earnings Miss and Stock Decline Amidst Operational Challenges UCB Q1 2026 Earnings Modest EPS Miss in a Quarter of Steady Performance FHI Q1 2026 Earnings EPS Surpasses Estimates by 63 Shares Edge Higher TRT Q3 2024 Earnings Modest Profitability Amidst Market Headwinds AGI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns Ecolab ECL Edges Higher as Support Holds Resistance in Sight Sharplink Inc SBET Declines 386 as Stock Nears Key Support at 592 Bluerock Acquisition Corp BLRK Holds Steady Near NAV Amid Merger Uncertainty CIMN Bonds Edge Lower as FixedIncome Market Pressures Persist Star Equity Holdings STRR Edges Higher Testing Key Resistance Near 1211 Firefly Aerospace FLY Surges 155 Key Levels to Watch Ascentage Pharma AAPG Advances 22 as Biotech Sector Finds Footing Calix Inc CALX Gains 283 as Support Holds Approaches Key Resistance Keysight Technologies KEYS Holds Above Support After Measured Gain VanEck Avalanche ETF VAVX Declines 351 as Support Level Comes into Focus VKI Invesco Advantage Municipal Income Trust II Edges Higher as YieldSeeking Demand Persists AIDriven Drug Discovery Could Accelerate Treatments for Brain Conditions Like MND DFTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Reports WiderThanExpected Loss Andersons Inc ANDE Edges Higher as Support Holds Resistance Test Potentially Ahead